THE PHARMACOKINETICS OF CEFUROXIME AXETIL IN THE SICK ELDERLY PATIENT

被引:14
作者
RIDGWAY, E
STEWART, K
RAI, G
KELSEY, MC
BIELAWSKA, C
机构
[1] WHITTINGTON HOSP,DEPT MICROBIOL,LONDON N19 5NF,ENGLAND
[2] WHITTINGTON HOSP,DEPT GERIATR MED,LONDON N19 5NF,ENGLAND
关键词
D O I
10.1093/jac/27.5.663
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The pharmacokinetics of cefuroxime axetil (RS3 formulation) were studied in 20 elderly patients following admission for lower respiratory or urinary tract infection. The mean age was 83·9 years. A 12-hourly dose of 250 mg was given for five days. The mean time to attain maximum serum concentration was 3.2 h with a mean peak concentration of 8·5 mg/1. The mean serum elimination half-life was 3.5 h and the AUC0-∞p 60.4 mg/h.l. There was no accumulation of the drug in the patients studied after five days treatment. The data suggest that the standard dosage regimen is adequate in the sick elderly patient. © 1991 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:663 / 668
页数:6
相关论文
共 12 条
[1]   ORAL CEFUROXIME AXETIL - CLINICAL-PHARMACOLOGY AND COMPARATIVE DOSE STUDIES IN URINARY-TRACT INFECTION [J].
ADAMS, DH ;
WOOD, MJ ;
FARRELL, ID ;
FOX, C ;
BALL, AP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 16 (03) :359-366
[2]   PHARMACOKINETIC PROPERTIES OF THE CEPHALOSPORINS [J].
BERGAN, T .
DRUGS, 1987, 34 :89-104
[3]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[4]  
DAVEY PG, 1988, ROYAL SOC MED SERVIC, V130, P7
[5]   CEFUROXIME - HUMAN PHARMACOKINETICS [J].
FOORD, RD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 9 (05) :741-747
[6]   PHARMACOLOGY OF CEFUROXIME AS THE 1-ACETOXYETHYL ESTER IN VOLUNTEERS [J].
HARDING, SM ;
WILLIAMS, PEO ;
AYRTON, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (01) :78-82
[7]  
HARDING SM, 1988, PRACTITIONER S, P62
[8]  
KELSEY MC, 1987, MANAGEMENT LOWER RES, P25
[10]  
STOKES EJ, 1987, CLIN MICROBIOLOGY, P37